Newborn screening samples are used to test more than 4 million
infants each year for life-threatening diseases that are treatable
if found at birth. These specimens also represent a potentially
invaluable resource for public health and biomedical research. The
IOM held a workshop to examine issues surrounding the use of
residual specimens for translational research.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!